ADHD
Attention, focus, executive function, and the conditions and treatments inside ADHD.
Reviewed by Shariq Refai, MD, MBA
ADHD is one of the most missed adult diagnoses in mental health, in part because the cultural script focuses on hyperactive children. This hub exists to make the adult presentations visible and to give the category a single clinical landing page.
ADHD is one of the most common and most under-diagnosed conditions in mental health, especially in adults. About 10 percent of US children meet criteria for ADHD; about 4 to 5 percent of US adults do, though most adult cases are missed because the cultural script around ADHD focuses on hyperactive children. The cluster of inattention, distractibility, executive function difficulty, and (in many but not all cases) hyperactivity persists into adulthood for roughly half of children diagnosed.
Inside the ADHD category, there are three diagnostic presentations: predominantly inattentive (sometimes called ADD), predominantly hyperactive-impulsive, and combined type. The inattentive presentation is the one most often missed in adults, especially women, because it lacks the visible motor activity that the cultural script associates with ADHD.
This hub maps the conditions, symptoms, and treatments that fall under the ADHD category. Treatment is well-evidenced and effective. Stimulant medication is first-line and works in roughly 70 percent of cases, with non-stimulants and behavioral approaches as additional options. If you arrived here because of a recent diagnosis or because you're starting to wonder, the hub is a useful entry point.
Conditions
ADHD
What ADHD is, how it shows up in children and adults, and what treatment looks like.
Strong ConditionTourette syndrome
What Tourette syndrome is, how it differs from other tic disorders, and what evidence-based treatment looks like.
Mixed ConditionOppositional defiant disorder
A childhood pattern of angry mood, arguing, defiance, and spite that goes well beyond normal misbehavior.
StrongPlanned coverage (6)
- ADHD inattentive presentation
- ADHD hyperactive impulsive presentation
- ADHD combined presentation
- Specific learning disorder
- Dyslexia
- Dyscalculia
Symptoms
Planned coverage (12)
- Inattention
- Distractibility
- Executive function difficulty
- Time blindness
- Working memory difficulty
- Hyperfocus
- Impulsivity
- Emotional dysregulation
- Disorganization
- Forgetfulness
- Difficulty sustaining attention
- Rejection sensitive dysphoria
Treatments
Planned coverage (14)
- Stimulant medications
- Methylphenidate based stimulants
- Amphetamine based stimulants
- Lisdexamfetamine
- Atomoxetine
- Guanfacine extended release
- Clonidine extended release
- Viloxazine
- Bupropion (off label for ADHD)
- Cognitive behavioral therapy for ADHD
- Behavioral therapy
- Parent training in behavior management
- ADHD coaching
- Executive function coaching
Glossary
Planned coverage (10)
- Executive function
- Working memory
- Dopamine
- Prefrontal cortex
- Hyperfocus
- Time blindness
- Stimulant rebound
- Rejection sensitive dysphoria
- Default mode network
- Connors rating scale
Treatment Overview
ADHD has some of the strongest evidence based treatment in psychiatry. Stimulant medications, the amphetamine class (lisdexamfetamine, mixed amphetamine salts) and the methylphenidate class (methylphenidate, dexmethylphenidate), are first line for most patients and produce a clinical response in roughly 70 to 80 percent of cases. Response is usually noticeable within days to weeks rather than the longer windows associated with antidepressants. Non stimulant medications (atomoxetine, viloxazine, guanfacine extended release, clonidine extended release) are second line and useful when stimulants aren't tolerated, when there's a co occurring anxiety disorder, when there's a substance use concern, or when steady all day coverage matters. Behavioral approaches, including cognitive behavioral therapy adapted for adult ADHD, parent training in behavior management for children, and executive function coaching, add meaningful benefit when paired with medication. School accommodations matter for children. Workplace accommodations matter for adults. Co occurring conditions (anxiety, depression, learning disorders, substance use) are common and need to be addressed alongside the ADHD treatment.
Resources and Support Organizations
The organizations below are independent of Shrinkopedia and the Shrink Network. We list them because they're recognized national resources, not because we have any financial or organizational relationship with them. Most are free at the point of access.
- CHADD (Children and Adults with Attention Deficit/Hyperactivity Disorder) National nonprofit providing education, advocacy, and support. Maintains a directory of professionals familiar with ADHD evaluation and treatment. chadd.org
- ADDA (Attention Deficit Disorder Association) Adult focused organization providing virtual support groups, professional directories, and educational resources. add.org
- American Professional Society of ADHD and Related Disorders (APSARD) Professional society for clinicians who treat ADHD. Hosts publicly available guidelines and adult ADHD evaluation resources. apsard.org
- International Dyslexia Association For co occurring learning disorders. Maintains evaluation directories and educational resources. dyslexiaida.org
- ADHD Foundation National charity providing education and support resources, internationally relevant. adhdfoundation.org.uk
- 988 Suicide and Crisis Lifeline Free, confidential, 24 hours a day in the United States for any mental health crisis. Call or text 988
- SAMHSA National Helpline Free, confidential treatment referral and information service for individuals and families facing mental health or substance use disorders. 1-800-662-4357 (HELP)
- Find Treatment (SAMHSA) Federal directory of evidence based mental health and substance use treatment providers, searchable by location and insurance. findtreatment.gov
ADHD frequently appears alongside anxiety and substance use. These adjacent hubs cover the overlap.
Across the network
How the network covers this topic.
The Shrink Network covers this topic at multiple layers. Below is a quick map of which site does what for this category. For the full cross-network cluster view, see the matching Network Cluster at /clusters/.
You are here: Shrinkopedia, the concept layer of The Shrink Network.
Understand the idea here first, then follow it to the property that takes it further.
Read a related condition →Want to understand more first?
- Understand the medication at PsychiatryRx →
- Protect your attention at QuitScrolling →
- Consider clinical evaluation at shrinkMD →
Disclosure: shrinkMD is the clinical care practice within The Shrink Network, the same network that publishes Shrinkopedia. Shrinkopedia takes no referral or affiliate commission for care.
See where this fits in the Atlas →